Monitoring body weight and physical activity in cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients diagnosed with pancreatic, esophageal, gastric, ovarian, or colorectal cancer who are scheduled for neo-adjuvant chemotherapy or primary surgery. Participants will receive a weight scale and an accelerometer to monitor their body weight and physical activity at home. The study aims to collect objective data on weight changes and activity levels, which are crucial for understanding and managing cancer cachexia. By utilizing advanced technology for data collection, the study seeks to improve the accuracy of cachexia diagnosis and management.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18
* Diagnosed with cancer
* Planned for curative-intent surgery or neo-adjuvant chemotherapy

Exclusion Criteria:

* ASA-classification V,
* severe liver cirrhosis Child grade C,
* end stage renal disease requiring dialysis,
* severe heart disease New York Heart Association class IV,
* chronic obstructive pulmonary disease (COPD) requiring (home)oxygen therapy,
* Patients must be "mobile". They may not be bedridden or in a wheelchair.

Where it's running

• Maastricht University Medical Center+
  Maastricht, Netherlands Recruiting
• Zuyderland Medical Center
  Sittard, Netherlands Recruiting

Study contacts

• Principal investigator: Steven Olde Damink, PhD, MSc., M.D. — Maastricht University Medical Center
• Study coordinator: Nicole Hildebrand, M.D.
• Email: nicole.hildebrand@mumc.nl
• Phone: +31 (0)43-3881584

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• DS010 in advanced cancer with cachexia: safety and early signals in adults

  This study tests DS010 in adults with cancer and cachexia to see if it is safe and whether it might help with their condition.

  Recruiting at 4 sites Phase 1/2 Dartsbio Pharmaceuticals Ltd. · Concord West, New South Wales and 3 other locations · NCT07921576

• Spatial multi-omics and AI-based early warning for pancreatic cancer cachexia

  This study tests whether spatial multi-omics data can reveal how the tumor and body metabolism interact in pancreatic cancer cachexia and whether a multimodal AI model can predict cachexia early in adults with pancreatic ductal adenocarcinoma.

  Recruiting Peking Union Medical College Hospital · Beijing · NCT07670286

• Hormones, Pain, and Exercise: Sports Bras for Full-Busted Women

  This study tests whether specially designed sports bras can reduce neck, shoulder, arm, and back pain in full-busted women, and whether hormones, inflammation, or brain changes affect pain.

  Recruiting Phase 1 University of Houston · Houston, Texas · NCT07579182

• Pathogenesis and Reversal Strategies for Cancer Cachexia Using Multi-Omics

  This study uses multiple omics methods and nutritional interventions to try to find causes and reversal strategies for cachexia in adults with gastrointestinal cancers.

  Recruiting China Medical University, China · Shenyang, Liaoning · NCT07519837

• GB18 injection for tumor cachexia in cancer patients

  This study tests GB18, a humanized GDF15 antibody, to see if it helps cancer patients with cachexia when given as subcutaneous injections.

  Recruiting at 2 sites Phase 1 Kexing Biopharm Co., Ltd. · Beijing, Beijing Municipality and 1 other locations · NCT07519564

• Nanocrystalline megestrol acetate with chemoradiation for locally advanced cervical cancer

  This Phase 1 trial tests whether taking nanocrystalline megestrol acetate by mouth can prevent or reduce weight and muscle loss in adults with locally advanced cervical cancer who are receiving concurrent chemoradiotherapy.

  Recruiting Phase 1 Second Xiangya Hospital of Central South University · Changsha, Hunan · NCT07338487

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.